Shenzhen Hepalink Pharmaceutical Group , Ltd. Profit Margin

As of the most recent data (June 2026), SHEZF shows a profit margin of 3.87%. That compares with 7.73% in the prior-year period — down 49.9% year over year. That is below the sector sector average of 13.2%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SHEZF's profit margin is now 3.87% (was 7.73%) — a 49.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Shenzhen Hepalink Pharmaceutical Group , Ltd. is outperforming or lagging.

The its sector sector average profit margin is about 13.2%. Shenzhen Hepalink Pharmaceutical Group , Ltd. is at 3.87%, which is lower that average. That is roughly 70.7% below the sector mean. Use the comparison chart on this page to see how SHEZF stacks up against individual peers as well.

That compares with 7.73% in the prior-year period — down 49.9% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Shenzhen Hepalink Pharmaceutical Group , Ltd. with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Shenzhen Hepalink Pharmaceutical Group , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 3.87%) with ownership activity and broader fundamentals.